Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where D. Rodriguez Abreu is active.

Publication


Featured researches published by D. Rodriguez Abreu.


Annals of Oncology | 2016

Survival in young adults diagnosed with follicular lymphoma.

V. Calvo; Mariano Provencio; J. Gomez Codina; D. Rodriguez Abreu; A. Rueda

1. Tannock I, Sternberg CN. Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy. Ann Oncol 2015 Dec 12 [epub ahead of print], doi: 10.1093/annonc/mdv600. 2. Parker C, Gillesen S, Heidenreich A, Horwich A. Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015; 26 (Suppl 5): v69–v77. 3. Vale CL, Burdett S, Rydzewska LHM et al. Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data. Lancet Oncol 2015 Dec 21 [epub ahead of print], doi: 10.1016/S1470-2045(15) 00489-1. 4. Fletcher J. Subgroup analyses: how to avoid being misled. BMJ 2007; 335: 96. 5. Scales CD, Jr, Canfield SE. Using results of a subgroup analysis. Urol Oncol 2011; 29(4): 462–466. 6. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c869. 7. Mukherjee S. The Laws of Medicine: Field Notes From an Uncertain Science. TED Books (2015) ISBN-13: 978-1476784847. http://www.ted.com.


Clinical & Translational Oncology | 2010

SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma

M. Provencio Pulla; J. Alfaro Lizaso; L. de la Cruz Merino; J. Guma I Padro; C. Quero Blanco; J. Gómez Codina; M. Llanos Muñoz; N. Martinez Banaclocha; D. Rodriguez Abreu; A. Rueda Domínguez


Annals of Oncology | 2016

Prevalence of PD-L1 expression in patients with non-small cell lung cancer screened for enrollment in KEYNOTE-001, -010, and -024

C. Aggarwal; D. Rodriguez Abreu; E. Felip; Enric Carcereny; M. Gottfried; T. Wehler; M-J. Ahn; M. Dolled-Filhart; J. Zhang; Yue Shentu; R. Rangwala; B. Piperdi; Paul Baas


Clinical & Translational Oncology | 2010

SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma

A. Rueda Domínguez; J. Alfaro Lizaso; L. de la Cruz Merino; J. Guma I Padro; C. Quero Blanco; J. Gómez Codina; M. Llanos Muñoz; N. Martinez Banaclocha; D. Rodriguez Abreu; M. Provencio Pulla


Annals of Oncology | 2018

1247PDPhase II multicenter, single arm, open label study of nivolumab in combination with ipilimumab in untreated patients with metastatic uveal melanoma (GEM1402.NCT02626962)

J.M. Piulats Rodriguez; L. de la Cruz Merino; Enrique Espinosa; L Alonso Carrión; S. Martin Algarra; R López-Castro; M T Curiel García; D. Rodriguez Abreu; A.J. Rullan Iriarte; A Berrocal Jaime


Annals of Oncology | 2018

1464PKEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes?

D. Rodriguez Abreu; M C Garassino; E Esteban; G Speranza; E. Felip; Manuel Domine; M J Hochmair; S F Powell; S Y-S Cheng; Helge Bischoff; N Peled; Rina Hui; Martin Reck; Edward B. Garon; M Boyer; F Grossi; R Jennens; J. Yang; M C Pietanza; Shirish M. Gadgeel


Annals of Oncology | 2017

1286TiPNeo-adjuvant chemo/immunotherapy for the treatment of resectable stage IIIA non-small cell lung cancer (NSCLC): A phase II multicenter exploratory study” NADIM trial

V. Calvo de Juan; A. Insa Molla; M. Cobo Dols; B. Massuti Sureda; Guillermo Lopez-Vivanco; J. Casal Rubio; J. De Castro; M. Majem Tarruella; R. Bernabé Caro; J. Gonzalez-Larriba; I.C. Barneto Aranda; Elisabet Nadal; A. Martinez Marti; N. Vinolas Segarra; M. Guillot Morales; D. Vicente Baz; C. Camps Herrero; M. Domine Gomez; D. Rodriguez Abreu; M. Provencio Pulla


Annals of Oncology | 2016

Phase II multi-centre, non randomized, open label study of nivolumab in combination with ipilimumab as first line in adults patients with metastatic uveal melanoma. GEM 14-02

A.J. Rullan Iriarte; Salvador Martín-Algarra; L. de la Cruz Merino; D. Rodriguez Abreu; Enrique Espinosa; A. Berrocal; R. López Castro; T. Curiel; P. Luna; A. Lorenzo; Josep M. Piulats


Annals of Oncology | 2016

GRAY-B: An open label multicenter phase-2 GEM study on ipilimumab and radiation in patients with melanoma and brain metastases

J.A. Lopez Martin; L. de la Cruz Merino; A.M. Arance Fernandez; A. Illescas; I. Valduviecu Ruiz; Audina M. Berrocal; J. Lopez-Torrecilla; I. Marquez Rodas; M.V. Soriano Teruel; A. Alvarez Gonzalez; M.L. Chust Vicente; D. Rodriguez Abreu; Roberto Cabrera; M.C. Peñas Sanchez; T. Curiel; E. Muñoz Couselo; Javier Aristu; A. Gomez-Caamano; J. Medina Martinez; Salvador Martín-Algarra


Annals of Oncology | 2016

Identification of exosomes in non-Hodgkin B-cell lymphomas. Prognostic usefulness in patients treated with rituximab-chemotherapy: a prospective, multicenter correlation study by the Spanish Lymphoma Oncology Group (GOTEL)

Mariano Provencio; M. Rodriguez-Balada; B. Cantos; Cristina Quero; R. García Arroyo; A. Rueda; C. Maximiano; D. Rodriguez Abreu; Antonio Sánchez; V. Garcia

Collaboration


Dive into the D. Rodriguez Abreu's collaboration.

Top Co-Authors

Avatar

Mariano Provencio

Autonomous University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Enrique Espinosa

Hospital Universitario La Paz

View shared research outputs
Top Co-Authors

Avatar

J. De Castro

Hospital Universitario La Paz

View shared research outputs
Top Co-Authors

Avatar

M. Llanos Muñoz

Hospital Universitario de Canarias

View shared research outputs
Top Co-Authors

Avatar

Manuel Domine

Autonomous University of Madrid

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eloisa Jantus-Lewintre

Polytechnic University of Valencia

View shared research outputs
Researchain Logo
Decentralizing Knowledge